Introduced March 5, 2026 by Maxine Waters · Last progress March 5, 2026
The resolution raises awareness of HIV risks—particularly for women and women of color—and encourages screening and prenatal care, but it is symbolic only and lacks funding or mandates, so its practical impact on services and outcomes may be limited.
Healthcare providers and patients will have clearer national recognition of HIV risks and testing recommendations, encouraging more routine HIV screening and stronger prenatal/perinatal screening that can reduce mother-to-child transmission.
Women and girls—especially women of color—will receive focused public attention through a designated National Women and Girls HIV/AIDS Awareness Day and highlighted disparities, which can spur targeted outreach, testing, prevention, and support programs.
Women, racial-ethnic-minority communities, low-income people, and patients at risk may see little practical benefit because the resolution is declarative and does not provide funding or create new programs to expand testing or services.
Low-income individuals and women could be harmed if emphasis on awareness crowds out attention to concrete actions (funding, service expansion, or policy changes) needed to close testing and prevention gaps.
Based on analysis of 2 sections of legislative text.
Designates March 10 as National Women and Girls HIV/AIDS Awareness Day and records findings on U.S. and global HIV statistics, disparities, prevention guidance, and drivers of risk.
Designates March 10 as National Women and Girls HIV/AIDS Awareness Day and sets out factual findings about the HIV/AIDS epidemic in the United States and worldwide. The text highlights U.S. case numbers and testing guidance, documents disproportionate impacts on women—especially women of color—and summarizes global trends, drivers of risk, and barriers to prevention and education. It calls for annual observance to raise awareness, promote testing and prevention, reduce stigma, and support education and services for women and girls.